7-PHENYLETHLAMINO-4H-PYRIMIDO4,5-D1,3 OXAZIN-2-ONE COMPOUNDS AS MUTANT 1DH1 AND 1DH2 INHIBITORS

摘要

A compound, as defined herein, or pharmaceutical composition containing the compound, for use in treating IDH1 or IDH2 mutant cancer and having the structure: (I).